The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
Cladribine in Treatment of Chronic Progressive Multiple Sclerosis
Lancet 344:3-13, Sipe,J.C.,et al, 1994
Should Cerebral Ischemic Events in Cancer Patients be Considered a Manifestation of Hypercoagulability
Stroke 25:1215-1218, Chaturvedi,S.,et al, 1994
Mild Head Injury
(Ed) , Semin Neurol 14:1-9294., Packard,R.C., 1994
Tizanidine Treatment of Spasticity Caused by Multiple Sclerosis:Results of a Double-Blinded, Placebo-Controlled Trial
Neurol 44:S34-S43, Smith,C.,et al, 1994
Chronic Systemic High-Dose Recombinant Interferon Alfa-2a Reduces Exacerbation Rate & MRI Signs in MS
Neurol 44:406-413, Durelli,L.,et al, 1994
4-Aminopyridine in the Treatment of Patients with Multiple Sclerosis:Long-term Efficacy and Safety
Arch Neurol 51:292-296, Polman,C.H.,et al, 1994
A Genetic Marker and Family History Study of the Upstate New York Multiple Sclerosis Cluster
Neurol 44:329-333, Schiffer,R.B.,et al, 1994
Long-Term Risk of Recurrent Stroke After a First-Ever Stroke:The Oxfordshire Community Stroke Project
Stroke 25:333-337, Burn,J.,et al, 1994
Failure of Aspirin Treatment After Stroke
Stroke 25:275-277, Bornstein,N.M.,et al, 1994
The Effects of 4-Aminopyridine in MS Pts:Randomized, Placebo-Controlled, Double-Blind, Concentration-Controlled, Crossover
Neurol 44:1054-1059, Bever,C.T.,et al, 1994
Hypertension and Risk of Stroke Recurrence
Stroke 25:1605-1610, Alter,M.,et al, 1994
Migraine and Migranous Stroke:Risk Factors and Prognosis
Neurol 43:2473-2476, Rothrock,J.,et al, 1993
Extracellular Hippocampal Glutamate and Spontaneous Seizure in the Conscious Human Brain
Lancet 341:1607-1610, 16271993., During,M.J.&Spencer,D.D., 1993
Clinical Features of Recurrent Embolization in Acute Cardioembolic Stroke
Stroke 24:1681-1685, Yasaka,M.,et al, 1993
Early Childhood Prolonged Febrile Convulsions, Atrophy & Sclerosis of Mesial Struc & Temporal Lobe Epilepsy:An MRI Study
Neurol 43:1083-1087, Cendes,F.,et al, 1993
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993
Long-Term Safety of Azathioprine Therapy in Multiple Sclerosis
Neurol 43:831-833, Amato,M.P.,et al, 1993
Risk Factors for Dementia Associated with Multiple Cerebral Infarcts:In Pred African-Amer Hospital-Based Pts
Arch Neurol 50:714-720, Gorelick,P.B.,et al, 1993
Acute Bacterial Meningitis in Adults, A Review of 493 Episodes
NEJM 328:21-28, Durand,M.L.,et al, 1993
Large Focal Tumor-Like Demyelinating Lesions of the Brain:Intermed Entity Between MS & Acute Dissem Encephalomyelitis?
Ann Neurol 33:18-27, Kepes,J.J., 1993
Magnetic Resonance Imaging Findings Associated with Cardiac Arrest
Stroke 24:1005-1014, Roine,R.O.,et al, 1993
Anterior Inferior Cerebellar Artery Territory Infarcts, Mechanisms and Clinical Features
Arch Neurol 50:154-161, Amarenco,P.,et al, 1993
Rate and Types of Fractures in Corticosteroid-Treated Multiple Sclerosis Patinets
Neurol 42:1389-1391, Troiano,R.A.,et al, 1992
Characteristics of Intractable Seizures Following Meningitis and Encephalitis
Neurol 42:1513-1518, Marks,D.A.,et al, 1992
Stroke in a Cohort of Patients with Homozygous Sickle Cell Disease
J Pediatr 120:360-366, Balkaran,B.,et al, 1992
A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992
Suicide and Multiple Sclerosis:An Epidemiological Investigation
JNNP 55:542-545, Stenager,E.N.,et al, 1992
Surgical Treatment of Cervical Spondylotic Myelopathy:Time for a Controlled Trial
Neurol 42:5-13, Rowland,L.P., 1992
Stroke Recurrence Within 2 Years After Ischemic Infarction
Stroke 22:155-161, Hier,D.B.,et al, 1991
A Prognostic System for Transient Ischemia or Minor Stroke
Ann Int Med 114:552-557, Kerman,W.N.,et al, 1991
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Association Between Tumor Necrosis Factor-x and Disease Progression in Patients with Multiple Sclerosis
NEJM 325:467-472, Shareif,M.K.&Hentges,R., 1991
Neurologic Aspects of Cobalamin Deficiency
Medicine 70:229-245, Healton,E.B.,et al, 1991
Significance of Seizures Associated with Extracorporeal Membrane Oxygenation
J Pediatr 119:789-792, Campbell,L.R.,et al, 1991
Central-Nervous-System Demyelination after Immunisation with Recombinant Hepatitis B Vaccine
Lancet 338:1174-1175, Herroelen,L.,et al, 1991
Wilson's Disease
In Oxford Textbook of Clin Hepatology, Oxford Univ Press, Vol 2, Ch 20. 1, p. 947, Sternlieb,I.&Scheinberg,I.H., 1991
Nontraumatic Parenchymal Brain Hemorrhages
Medicine 69:277-295, Weisberg,L.A.,et al, 1990
Seizures and Other Neurologic Sequelae of Bacterial Meningitis in Children
NEJM 323:1651-1657, Pomeroy,S.L.,et al, 1990
Efficacy & Toxicity of Cyclosporine in Chronic Progressive Multiple Sclerosis:A Randomized Clinical Trial
M. S. Study Group, Ann Neurol 27:591-605, 5890., , 1990
Predisposing Factors of Recurrent Embolization in Cardiogenic Cerebral Embolism
Stroke 21:1000-1007, Yasaka,M.,et al, 1990
Preliminary Trial of 3, 4-Diaminopyridine in Patients with Multiple Sclerosis
Ann Neurol 27:421-427, Bever,C.T.,et al, 1990
Neurologic Sequelae of Open-Heart Surgery in Children
Am J Dis Child 144:369-373, Ferry,P.C., 1990
Status Epilepticus in Adults
Lancet 336:551-552, Brodie,M.J., 1990
Orally Administered 4-Aminopyridine Improves Clinical Signs in Multiple Sclerosis
Ann Neurol 27:186-192, Davis,F.A.,et al, 1990
Neurological Disease Associated with Antiphospholipid Antibodies
Ann Neurol 25:221-227, Briley,D.P.,et al, 1989
Site and Pathogenesis of Infarcts Associated with Carotid Endarterectomy
Stroke 20:324-328, Krul,J.M.J.,et al, 1989
Stroke in the Lehigh Valley:Combined Risk Factors for Recurrent Ischemic Stroke
Neurol 39:669-672, Sobel,E.,et al, 1989
Determinants of Early Recurrence of Cerebral Infarction, The Stroke Data Bank
Stroke 20:983-989, Sacco,R.L.,et al, 1989
Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989